These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Takada H; Kishimoto C; Hiraoka Y Circulation; 1995 Sep; 92(6):1604-11. PubMed ID: 7664447 [TBL] [Abstract][Full Text] [Related]
6. L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes. Okabe TA; Hattori M; Yuan Z; Kishimoto C Int J Exp Pathol; 2008 Oct; 89(5):382-8. PubMed ID: 18808530 [TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence. Kiel RJ; Smith FE; Chason J; Khatib R; Reyes MP Eur J Epidemiol; 1989 Sep; 5(3):348-50. PubMed ID: 2551723 [TBL] [Abstract][Full Text] [Related]
8. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975 [TBL] [Abstract][Full Text] [Related]
9. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Hiraoka Y; Kishimoto C; Takada H; Kurokawa M; Ochiai H; Shiraki K; Sasayama S Cardiovasc Res; 1993 Jun; 27(6):957-61. PubMed ID: 8221785 [TBL] [Abstract][Full Text] [Related]
10. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699 [TBL] [Abstract][Full Text] [Related]
11. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis. Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. Kishimoto C; Thorp KA; Abelmann WH Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299 [TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. Kishimoto C; Kurokawa M; Ochiai H J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice. Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374 [TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647 [TBL] [Abstract][Full Text] [Related]
16. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051 [TBL] [Abstract][Full Text] [Related]
17. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage. Kishimoto C; Abelmann WH Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533 [TBL] [Abstract][Full Text] [Related]
18. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice. Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713 [TBL] [Abstract][Full Text] [Related]
19. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. Kishimoto C; Crumpacker CS; Abelmann WH J Am Coll Cardiol; 1988 Nov; 12(5):1334-41. PubMed ID: 2844874 [TBL] [Abstract][Full Text] [Related]
20. Role of MIP-2 in coxsackievirus B3 myocarditis. Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]